Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up

Published:2024-08-14 Issue:9 Volume:65 Page:1409-1415
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Severi Stefano,Grassi Ilaria,Bongiovanni Alberto,Nicolini Silvia,Marini Irene,Arpa Donatella,Ranallo Nicoletta,Azzali Irene,Di Iorio Valentina,Sarnelli Anna,Manuela Monti,Amadori Elena,Fabbri Lucia,Bartolini Daniela,Tosatto Luigino,Di Meco Francesco,Gurrieri Lorena,Riva Nada,Calabro Luana,Matteucci Federica,Paganelli Giovanni,Sansovini Maddalena

Publisher

Society of Nuclear Medicine

Reference27 articles.

1. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014

2. An overview of meningiomas;Buerki;Future Oncol.,2018

3. Radiation-Induced meningiomas after childhood brain tumor: a magnetic resonance imaging screening study;Remes;J Adolesc Young Adult Oncol.,2019

4. EANO guideline on the diagnosis and management of meningiomas

5. Meningioma: not always a benign tumor—a review of advances in the treatment of meningiomas;Maggio;CNS Oncol.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP